FDA Inspection 1111975 — Aspirus Wausau Hospital IRB

Aspirus Wausau Hospital IRB — FEI 3003923970

The FDA completed an inspection of Aspirus Wausau Hospital IRB on December 5, 2019 in Wausau, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 5, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Wausau, WI (United States)

Additional Details

IRB

Citations

IDCFRDescription
731821 CFR 56.115(a)(2)Minutes of IRB meetings
733421 CFR 56.115(a)(5)List of members